Biomarker News and Research RSS Feed - Biomarker News and Research

A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular marker and signature molecule.
microDimensions to host two compact digital pathology webinars on 11 October, 2016

microDimensions to host two compact digital pathology webinars on 11 October, 2016

microDimensions is hosting two compact digital pathology webinars back to back on Oct 11th. [More]
Researchers develop new analytical capabilities to identify chemical forms of mercury in human hair

Researchers develop new analytical capabilities to identify chemical forms of mercury in human hair

Mercury is a potent neurotoxin present in our daily lives and our body can accumulate it over the years. Food consumption, such as fish and rice, is the most common source of mercury exposure. [More]
Desalination can increase prevalence of inadequate iodine intake

Desalination can increase prevalence of inadequate iodine intake

Hebrew University study suggests that desalination can dramatically increase the prevalence of inadequate iodine intake. [More]
ATS releases new clinical practice guidelines for diagnosis, management of LAM

ATS releases new clinical practice guidelines for diagnosis, management of LAM

The American Thoracic Society and the Japanese Respiratory Society have published new clinical practice guidelines for the diagnosis and management of lymphangioleiomyomatosis (LAM), a rare lung disease that primarily affects women of child-bearing age. [More]
Researchers develop method to predict disease activity in multiple sclerosis

Researchers develop method to predict disease activity in multiple sclerosis

Cells in the immune system of patients with multiple sclerosis behave differently from those of healthy individuals. Researchers at Linköping University in Sweden have exploited this difference to develop a method that can predict disease activity in multiple sclerosis. [More]
BET inhibitors could be powerful new therapeutic strategy for ovarian cancer

BET inhibitors could be powerful new therapeutic strategy for ovarian cancer

Few effective treatments have been approved to treat ovarian cancer, the deadliest of all cancers affecting the female reproductive system. [More]
UAB researchers find microRNA as potential therapeutic target for MDD

UAB researchers find microRNA as potential therapeutic target for MDD

A tiny RNA appears to play a role in producing major depression, the mental disorder that affects as many as 250 million people a year worldwide. [More]
New biomarker test helps detect autoimmune-induced neuropsychiatric disorders

New biomarker test helps detect autoimmune-induced neuropsychiatric disorders

A research team from the University of Oklahoma Health Sciences Center, led by Madeleine Cunningham, Ph.D., in conjunction with the National Institute of Mental Health, has developed the first-of-its-kind biomarker test to help detect autoimmune-induced neuropsychiatric disorders. [More]
Researchers unlock genetic code that disrupts response to breast cancer therapy

Researchers unlock genetic code that disrupts response to breast cancer therapy

Scientists may have unlocked the genetic code that determines why many patients with estrogen receptor-positive breast cancer fail to respond to the widely used drug tamoxifen. [More]
Good blood microcirculation linked to longevity

Good blood microcirculation linked to longevity

Human longevity has been previously linked by researchers to genetic factors, calorie restriction, and certain life-style factors such as physical activity or the Mediterranean diet. [More]
DNA-binding protein CHD1 could be potential biomarker for targeted prostate cancer treatment

DNA-binding protein CHD1 could be potential biomarker for targeted prostate cancer treatment

The loss of CHD1, one of the most frequently mutated genes in prostate tumors, sensitizes human prostate cancer cells to different drugs, including PARP inhibitors. [More]
Using biomarkers to diagnose sepsis: an interview with Jordi Trafi

Using biomarkers to diagnose sepsis: an interview with Jordi Trafi

Sepsis, according to the new clinical definition of sepsis, is organ dysfunction caused by the body’s dysregulated response to an infection. Sepsis is common, with about 20 million patients/year in the developed world. It can escalate to septic shock, which is a life-threatening condition with a mortality rate of about 40%. In fact, about every second someone in the world dies of sepsis. [More]
Myeloid-derived suppressor cells may serve as biomarkers for idiopathic pulmonary fibrosis

Myeloid-derived suppressor cells may serve as biomarkers for idiopathic pulmonary fibrosis

Researchers at Helmholtz Zentrum München, a partner in the German Center for Lung Research, have discovered that the number of myeloid-derived suppressor cells (MDSC) is increased in the blood of patients with idiopathic pulmonary fibrosis (IPF). [More]
Study highlights possible reasons for MS misdiagnosis

Study highlights possible reasons for MS misdiagnosis

A number of common conditions are mistaken for multiple sclerosis (MS), a disabling central nervous system disease, say researchers at four academic medical centers across the U.S in a study published online August 31, 2016 in the journal Neurology. [More]
Research findings could lead to new biomarker for early stages of tumor development

Research findings could lead to new biomarker for early stages of tumor development

To treat or not to treat? That is the question researchers at the Department of Energy's Lawrence Berkeley National Laboratory hope to answer with a new advance that could help doctors and their cancer patients decide if a particular therapy would be worth pursuing. [More]
Radiometer announces sponsorship for World Sepsis Day 2016

Radiometer announces sponsorship for World Sepsis Day 2016

Radiometer is proud to announce that it is sponsoring this year’s World Sepsis Day on the 13th September, continuing its commitment to the fight against this life-threatening medical condition. [More]
Investigational biomarker surpasses current gold standard test for identifying brain shunt infections

Investigational biomarker surpasses current gold standard test for identifying brain shunt infections

In a study of children with brain shunts at Children's of Alabama, a University of Alabama at Birmingham investigational biomarker outperformed the current "gold standard" test for detecting bacterial infections in the shunts. [More]
New NCCN Imaging AUC released for eight new cancers

New NCCN Imaging AUC released for eight new cancers

The National Comprehensive Cancer Network, a Centers for Medicare & Medicaid Services-approved provider-led entity for imaging appropriate use criteria, continues to build its library of AUC and has published NCCN Imaging Appropriate Use Criteria for eight new cancer types. Launched in June 2016, NCCN Imaging AUC currently are available for 20 cancer types. [More]
Fluid-filled sacs that brain cells make to trap amyloid may contribute to Alzheimer's disease

Fluid-filled sacs that brain cells make to trap amyloid may contribute to Alzheimer's disease

Vesicles, fluid-filled sacs that brain cells make to trap amyloid, a hallmark of Alzheimer's, appear to also contribute to the disease, scientists report. [More]
Boehringer Ingelheim and Duke expand collaboration to create largest patient registry for idiopathic pulmonary fibrosis (IPF)

Boehringer Ingelheim and Duke expand collaboration to create largest patient registry for idiopathic pulmonary fibrosis (IPF)

Boehringer Ingelheim Pharmaceuticals, Inc. and the Duke Clinical Research Institute (DCRI) announced today the expansion of the Idiopathic Pulmonary Fibrosis – PROspective Outcomes (IPF-PRO) Registry, a patient registry developed to uncover insights into IPF, a rare and serious lung disease. The expansion will increase the study enrollment from 300 patients at 18 study sites to 1,500 patients at approximately 45 sites, creating the largest registry of newly diagnosed IPF patients. [More]
Advertisement
Advertisement